The specific thresholds that should prompt dose reduction or discontinuation include: ALT or AST elevation exceeding 3 times the patient's baseline value, new or worsening coagulopathy (INR increase of 0.5 or more from baseline), albumin decline below 2.5 g/dL, or new clinical signs of hepatic decompensation such as worsening ascites, encephalopathy, or jaundice [5]
Medical providers typically prescribe 100mg to 600mg of glutathione for the patients general well-being and cell regeneration
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., et al
M.GordonH
PMID 19570099
While injectable BPC-157 enters systemic circulation immediately, oral administration allows both local GI therapeutic effects and systemic distribution